Navigation Links
ATCC and Evercyte Form a Partnership to Develop and Distribute Immortalized Human Cells and Cell Lines
Date:12/3/2013

Manassas, VA (PRWEB) December 03, 2013

ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply of physiologically relevant cells for extended studies in biological, medical, pharmaceutical, cosmetic, and toxicological research.

The partnership brings together the expertise of both organizations. Evercyte systematically establishes and functionally characterizes immortalized human cell lines from specific tissues and donors. ATCC provides extensive cell manufacturing and testing capabilities to assure the cell lines are fully defined and meet quality standards. Together, the organizations are making these unique cell lines available to the scientific community through existing global distribution channels.

“At ATCC, we’ve set the standard for providing the largest and most diverse collection of authenticated biological materials to the scientific community since 1925,” said Sharon Challberg, Principal, Corporate Development at ATCC. “Our mission is to provide biological materials for the advancement and application of scientific knowledge. This strategic partnership with Evercyte expands our ability to do so through a series of unique immortalized cell lines.”

“A key success factor of this partnership is the strength of the technical teams at both ATCC and Evercyte, given the combined years of experience in cell line development, characterization, and manufacturing,” said Chengkang Zhang, Ph.D., the technical lead for this program at ATCC.

Johannes Grillari, CSO of Evercyte, said, “Our core expertise is to systematically establish and characterize innovative, immortalized human cell cultures for cell based assays in pharmaceutical, chemical, and cosmetic industries as well as in ecotoxicology. With ATCC as a partner, high quality large-scale production of immortalized cell material is assured. Our mutual customers can develop standardized, relevant and reproducible cell based model systems and assays. In addition, ATCC’s world-wide distribution network is a perfect match for Evercyte, especially in regard to customers in academia,” Dr. Grillari added.

For more information about immortalized cell lines from ATCC and Evercyte, please visit http://www.atcc.org.

About ATCC
ATCC serves and supports the scientific community with industry-standard products and innovative solutions. With the world’s largest and most diverse collection of human, animal and plant cell lines, molecular genomic tools, microorganisms and biological products, ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. ATCC is a non-profit organization with headquarters in Manassas, VA.

About Evercyte
By developing immortalized cells and cell lines that retain their parental characteristics, Evercyte seeks to accelerate drug discovery and development. Evercyte produces and delivers single immortalized cell strains, including mesenchymal stem cells that can be differentiated to the cell type of interest; cell panels with cell strains derived from different tissues or from donors of various health statuses; and as a service, offers customer- tailored immortalized cell strain development as well as cell based assay development. Evercyte is a spin-off company of the Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11373736.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fertility Centers of New England Announces Partnership with CapexMD Fertility Financing
2. CESI Announces Partnership with Visiting Angels Home Care Agency to Address Financial Needs of A Growing, Aging Population
3. Progressive Dental Marketing CEO Cites Mutual Benefits of Strategic Referral Partnerships
4. Georgetown University 50-State Report Finds More Children Have Health Coverage - Attributes Gains to Successful Federal State Partnership Programs Medicaid and CHIP
5. Health Data Intelligence Announces Strategic Partnership with Predictive Analytics Technology Leader Analytics Inside
6. PolyU Gears Up for Aviation Services Research in Partnership with Boeing
7. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
8. BeachLifestyle and The Total Education Network Announce Their Partnership as the Simply G Media Network
9. NBA Basketball Star Stephen Curry Extends Partnership with Zamst to Stabilize Ankle
10. Mission: Medical Spanish - Canopy Apps & AMSA Partnership to Drive Medical Spanish Training at All 173 Medical Schools
11. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... June 8, 2017   Responding to Heath Ledger,s ... the death of singer Chris Cornell in May, ... International offers a free online psychiatric drug ... and families about psychotropic drug risks. The ... died from an accidental overdose, has called for tighter rules ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/5/2017)... 5, 2017 Kohll,s Pharmacy & Homecare is the first ... United States . The Raizer is a simple battery ... up to an almost-standing position within a few ... one assistant and does not require any extra effort ... a child can operate it, and lightweight and ...
Breaking Medicine Technology: